27 participants
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2025-05-05
- Completion:
- 2027-06-01
Conditions
- Metastatic Urothelial Carcinoma
- Unresectable Urothelial Carcinoma
Interventions
- PROCEDURE
- BIOLOGICAL
No Results Yet